Valuation : Dr. Reddy's Laboratories Limited

Market Cap 967B 10.12B 8.72B 8.26B 7.49B 14.04B 14.11B 98.08B 37.72B 492B 38.02B 37.18B 1,555B P/E 2027 *
25.7x
P/E 2028 * 20x
Enterprise Value 936B 9.79B 8.44B 7.99B 7.24B 13.58B 13.65B 94.88B 36.49B 476B 36.78B 35.97B 1,504B EV / Sales 2027 *
2.66x
EV / Sales 2028 * 2.33x
Free-Float
69.71%
Yield 2027 *
0.65%
Yield 2028 * 0.72%
1 day+2.18%
1 week-0.21%
Current month-1.53%
1 month-4.06%
3 months-10.59%
6 months-17.85%
Current year-14.92%
1 week 11.67
Extreme 11.67
12.03
1 month 11.67
Extreme 11.67
12.51
Current year 11.36
Extreme 11.36
15.67
1 year 11.36
Extreme 11.36
15.67
3 years 11.36
Extreme 11.36
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2019
Director of Finance/CFO - 31/07/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 12/05/2014
Chairman 65 01/04/2013
Director/Board Member 65 24/10/2018
Change 5-day change 1-year change 3-year change Capi.($)
+2.18%-0.21% - - 9.94B
+0.08%-2.25%+48.55%+88.64% 1,001B
-0.23%-3.31%+49.09%+63.61% 642B
+1.05%+0.39%+16.91%+72.75% 451B
-0.38%-3.59%+28.24%+35.57% 340B
-0.09%-13.54%+10.08%+26.87% 263B
-0.43%-2.48%-2.07%+11.48% 247B
-0.61%-13.08%+34.41%+45.20% 207B
-3.44%-7.51%-20.08%-59.58% 197B
-0.65%-4.60%+22.22%+86.98% 180B
Average -0.22%-5.53%+20.82%+41.28% 391.82B
Weighted average by Cap. -0.19%-4.65%+30.24%+56.03%

Financials

2027 *2028 *
Net sales 352B 3.68B 3.17B 3B 2.72B 5.11B 5.13B 35.68B 13.72B 179B 13.83B 13.53B 566B 393B 4.11B 3.54B 3.35B 3.04B 5.7B 5.73B 39.83B 15.32B 200B 15.44B 15.1B 631B
Net income 37.21B 390M 336M 318M 288M 540M 543M 3.77B 1.45B 18.93B 1.46B 1.43B 59.82B 48.98B 513M 442M 418M 379M 711M 715M 4.97B 1.91B 24.92B 1.93B 1.88B 78.74B
Net Debt -31.58B -331M -285M -270M -244M -459M -461M -3.2B -1.23B -16.07B -1.24B -1.21B -50.77B -51.62B -540M -466M -441M -400M -750M -753M -5.24B -2.01B -26.26B -2.03B -1.98B -82.98B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
11/09/26 US$11.95 +2.01% 1,203,600
10/09/26 US$11.71 -1.43% 2,931,083
09/09/26 US$11.88 0.00% 3,502,224
08/09/26 US$11.88 -0.75% 2,134,903
04/09/26 US$11.97 -0.50% 2,343,590
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,161.00INR
Average target price
1,265.77INR
Spread / Average Target
+9.02%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!